At ACMG 2025, Illumina demonstrates how whole-genome sequencing and improved bioinformatics has solved cases of rare genetic disease
Here’s why Illumina is uniquely positioned to bring multiomics to scale
Four UX design staff share the ideas and innovations that became the MiSeq i100 Series
.jpg)
On Rare Disease Day, we talked with EURORDIS on how thousands of patient surveys can inform the future of diagnostics, care, and policies
| Date | Publication | Title |
|---|---|---|
| Mar 21, 2025 | Health Tech World | Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery |
| Mar 20, 2025 | Endpoints | Illumina was built on DNA. Its future could be biology’s next big wave |
| Mar 6, 2025 | Africa CDC | Renewed Commitment to Strengthen Public Health Surveillance and Address Disease Outbreaks in Africa |
| Mar 5, 2025 | GenomeWeb | Genome Canada Launches C$200M Initiative to Analyze 100K Diverse Genomes |
| Mar 4, 2025 | GenomeWeb | Spatial Omics, Single-Cell Companies Provide Updates, Roadmaps at AGBT |
At Illumina, we push boundaries. We think beyond the conventional. We dream big. With the energy of so many bright and accomplished people, the opportunities are endless.
Search for JobsIf you are a member of the media:
If you are not a member of the media, please visit Contact Us.
